TrialHuman vaccines & immunotherapeutics2020

Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture.

Mikhail F Vorovitch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.